Sequencing Axatilimab and Safety

Panelists discuss where and when sequencing axatilimab becomes appropriate within the clinical setting, as well as safety precautions associated with the drug.

EP: 1.Overview of Graft-Versus-Host Disease

EP: 2.Overview of Chronic Graft-Versus-Host Disease, and AGAVE-201 Study Design

EP: 3.Results of the AGAVE-201 Study

Now Viewing

EP: 4.Sequencing Axatilimab and Safety

Recent Videos